MYQORZO
Live / Registered — Registered (as of 17 Mar 2026)
What this means for you
Registered since 17 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97619234
- Registration number
- 8178765
- Mark type
- Stylized text
- Filed
- 04 Oct 2022
- Published for opposition
- 24 Jan 2023
- Registered
- 17 Mar 2026
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies
Owner
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
Prosecution history
- 17 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Feb 2026 — USE AMENDMENT FILED
- 05 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 05 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jan 2026 — SOU EXTENSION 5 GRANTED
- 17 Aug 2025 — SOU EXTENSION 5 FILED
- 31 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2025 — SOU EXTENSION 4 GRANTED
- 10 Feb 2025 — SOU EXTENSION 4 FILED